New shoulder implant tracked for 10 years in 73 patients

NCT ID NCT03312465

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study follows 73 people who received a shoulder replacement using the Anatomical Shoulder Domelock System. The goal is to see how well the device works and how safe it is over 10 years. Participants have conditions like arthritis or avascular necrosis and have not improved with other treatments.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Anatomical Shoulder Domelock System (a shoulder replacement device)
What this could lead to
If successful, this could confirm that the device is a safe and effective option for shoulder replacement, helping to reduce pain and improve function.
What could go wrong
This is a post-market study with no control group, so results may not prove the device is better than other options. Some patients may experience complications like implant failure or need for revision surgery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARTHRITIS, DEGENERATIVE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • HELIOS ENDO-Klinik Hamburg

    Hamburg, Germany

  • Krankenhaus Maria Hilf

    Daun, Germany

  • Royal Derby Hospital

    Derby, DE22 3NE, United Kingdom

  • Univeritätklinik Bagrist

    Zurich, Canton of Zurich, 8008, Switzerland

  • Universitaire Ziekenhuizen Leuven

    Leuven, Belgium

  • Universitätsspital Basel

    Basel, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.